Drug
MK0767 clinical trials
Also written MK0767.
- studies test it
- 10
- open now
- 0
- in phase 3
- 8
- first study started
- 2001
How studies write it
Studies that test it under each name
Development codes
- MK0767
- 10
Studies by the year they started
10 studies that test it; most in 2003 (7)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses MK0767 is read from its arms, and is right about nine times in ten.
Testing it · 10
- MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543816Written as MK0767
- MK0767 and Metformin Combination Study (0767-028)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543738Written as MK0767
- Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543751Written as MK0767
- MK0767 in Type 2 Diabetes (0767-012)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00543556Written as MK0767
- Dyslipidemia in Type 2 Diabetes (0767-034)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00547274Written as MK0767
- MK0767 and Sulfonylurea Combination Study (0767-027)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543491Written as MK0767
- MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543010Written as MK0767
- MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00703690Written as MK0767
- Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00543361Written as MK0767
- Study A - MK0767 Monotherapy StudyTerminatedPhase 3Merck Sharp & Dohme LLCNCT00543517Written as MK0767